SEC CIK 1642439
Scavilla Daniel T
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| XRAYview stock → | 157,754 | 2026-05-22 |
| GMEDview stock → | 0 | 2024-11-21 |
Position History — GMED
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GMED
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-01-23 | Grant / award (derivative) | 140,000 | $0.00 | 140,000 |
| 2024-11-21 | Option exercise (derivative) | 50,000 | $0.00 | 0 |
| 2024-11-21 | Open-market sale | 130,000 | $85.00 | 0 |
| 2024-11-21 | Option exercise | 80,000 | $43.58 | 130,000 |
| 2024-11-21 | Option exercise | 50,000 | $43.77 | 50,000 |
| 2024-11-06 | Option exercise (derivative) | 30,000 | $0.00 | 0 |
| 2024-11-06 | Option exercise (derivative) | 30,000 | $0.00 | 50,000 |
| 2024-11-06 | Option exercise | 30,000 | $26.27 | 30,000 |
| 2024-11-06 | Option exercise | 30,000 | $43.77 | 60,000 |
| 2024-11-06 | Open-market sale | 60,000 | $80.02 | 0 |
| 2024-01-26 | Grant / award (derivative) | 140,000 | $0.00 | 140,000 |
| 2023-10-10 | Grant / award (derivative) | 10,000 | $0.00 | 10,000 |
| 2023-01-26 | Grant / award (derivative) | 100,000 | $0.00 | 100,000 |
| 2022-04-21 | Grant / award (derivative) | 60,000 | $0.00 | 60,000 |
| 2022-01-27 | Grant / award (derivative) | 40,000 | $0.00 | 40,000 |
| 2021-07-02 | Option exercise (derivative) | 50,000 | $0.00 | 30,000 |
| 2021-07-02 | Option exercise (derivative) | 50,000 | $0.00 | 0 |
| 2021-07-02 | Open-market sale | 400 | $78.97 | 0 |
| 2021-07-02 | Open-market sale | 99,600 | $78.41 | 400 |
| 2021-07-02 | Option exercise | 50,000 | $25.52 | 50,000 |
| 2021-07-02 | Option exercise | 50,000 | $26.27 | 100,000 |
| 2021-01-14 | Grant / award (derivative) | 50,000 | $0.00 | 50,000 |
| 2020-05-21 | Option exercise (derivative) | 68,750 | $0.00 | 50,000 |
| 2020-05-21 | Option exercise (derivative) | 31,250 | $0.00 | 0 |
| 2020-05-21 | Open-market sale | 100,000 | $55.09 | 0 |
| 2020-05-21 | Option exercise | 68,750 | $25.52 | 100,000 |
| 2020-05-21 | Option exercise | 31,250 | $25.40 | 31,250 |
| 2020-01-22 | Grant / award (derivative) | 80,000 | $0.00 | 80,000 |
| 2019-01-22 | Grant / award (derivative) | 80,000 | $0.00 | 80,000 |
| 2018-04-10 | Option exercise (derivative) | 50,540 | $0.00 | 31,250 |
| 2018-04-10 | Option exercise (derivative) | 31,250 | $0.00 | 118,750 |
| 2018-04-10 | Option exercise | 50,540 | $25.40 | 50,540 |
| 2018-04-10 | Option exercise | 31,250 | $25.52 | 31,250 |
| 2018-04-10 | Open-market sale | 31,250 | $50.00 | 0 |
| 2018-04-09 | Option exercise (derivative) | 18,210 | $0.00 | 81,790 |
| 2018-04-09 | Option exercise | 18,210 | $25.40 | 18,210 |
| 2018-04-09 | Open-market sale | 18,210 | $50.00 | 0 |
| 2018-01-22 | Grant / award (derivative) | 80,000 | $0.00 | 80,000 |
| 2017-01-30 | Grant / award (derivative) | 80,000 | $0.00 | 80,000 |
| 2016-01-25 | Grant / award (derivative) | 150,000 | $0.00 | 150,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.